Abstract
Considering the accelerated pace of new cases emergence of tuberculosis (TB), about 10 million per year, the high rates of resistance to main classes of antimicrobials, and taking into account that TB occupies the first place in the ranking of causes of death by an infectious agent, becomes evident the need to control and combat this disease which poses a serious threat to global public h…